Health Innovation Manchester (HInM) has published its Impact Report for 2022-2023.

The report details how HInM has delivered against all its key commissions from NHS England and the Office of Life Sciences through 2022/23.

Key highlights in the report include:

  • Strong delivery against all national AHSN requirements across its various commissions including delivery to the requirements of NHS England and Office of Life Sciences commissions.
  • Success in the Manchester Biomedical Research Centre bid, which has been awarded £59.1m over five years, a significant uplift on the previous settlement.
  • Successfully securing a grant from Innovate UK and industry investment for a circa £20m innovation accelerator programme.
  • Leading on the design and development of a GM approach for virtual wards, which is now currently delivering >400 virtual beds across the system.
  • Grown the use of GM Care Record by around 25% in year to 19,000 users and 190,000 patient consultations per month, and driven academic outputs from the GM Care Record (3 publications, 42 studies in the pipeline overall).
  • Led the successful wave 1 NHS England Secure Data Environment bid process for GM and the wider NW region, securing £11m over three years.
  • Led on successful bids through 2022/23 to leverage over £100m of investment into the GM system.
  • Ten principles of health equity for innovators

    “Health equity is the attainment of the highest level of health for ALL people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and social determinants of health — and to eliminate disparities in health and health care.” (health.gov) Within the NHS there [...]

  • Collaborating to improve access and equity of care for sickle cell sufferers

    Sickle cell disease (SCD) is a serious and lifelong health condition. People with SCD produce unusually shaped red blood cells that can cause problems because they do not live as long as healthy blood cells and can block blood vessels. This can result in suffers experiencing painful episodes, called sickle cell crises, as well as anaemia, [...]

  • Until tackling health inequalities becomes business as usual, innovation is our best chance of equity

    At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made across the system to better support some of our most under-served communities. To maintain this momentum, we must not just embed tackling health and healthcare inequalities in all that we do, [...]